Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: DiaDexus and Beyond Genomics Ink Cancer-Based Research Collaboration

NEW YORK, Feb. 7 - Systems biology company Beyond Genomics has struck a research collaboration with DiaDexus, GenomeWeb has learned.


Stephen Ober, president of Beyond Genomics, on Thursday confirmed the account initially disclosed by sources close to both companies. "We did close a deal a couple of days ago with DiaDexus," said Ober.


It would be the second partnership for startup Beyond Genomics. The company's maiden deal was inked last May with Elan Pharmaceuticals to apply its systems biology techniques to Alzheimer's research.


The deal with DiaDexus is "a little different" from the Elan partnership, said Ober. "It is a research collaboration in the area of oncology and it has some components that are similar but some are different from the Elan transaction."

He would not disclose terms of the deal.


A source close to one of the companies said on Wednesday that DiaDexus, which uses genomic sequence data to develop diagnostic and therapeutic targets with a special focus on cancer, is unable to comment because it is in a silent period that precedes an IPO.

In its deal with Elan, Beyond Genomics got a $5 million equity investment in exchange for a two-year commitment to help the pharma giant find biomarkers and drug targets for Alzheimer's disease.

"In addition to providing clinical expertise and support for the program, Elan will grant the joint venture a non-exclusive license to an important animal model, a mouse strain which develops many of the features of the human disease," Stephen Ober, president of Cambridge, Mass.-based Beyond Genomics, said in May.

At the time, Elan Pharmaceuticals said it believed Beyond Genomics' technology could potentially help to uncover new proteins at play in Alzheimer's.


Beyond Genomics aims to increase the current level of throughput achieved by existing technologies and combine this capability with the ability to generate genomics, proteomics, and metabolite data.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.